Stocks · Health care · Pharmaceutical Preparations

Korro Bio, Inc.

KRRO Clue Score32
United States Fiscal year ends December CIK 0001703647 Results filed 5 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
David L. Lucchino
18 Jan 2022
President and CEO
Exercised, kept
6,905
$0.61
$4.21K
David L. Lucchino
20 Dec 2021
President and CEO
Exercised, kept
6,905
$0.61
$4.21K
David L. Lucchino
2 Nov 2021
President and CEO
Exercised, kept
6,905
$0.61
$4.21K
David L. Lucchino
5 Oct 2021
President and CEO
Exercised, kept
6,905
$0.61
$4.21K
David L. Lucchino
3 Sep 2021
President and CEO
Exercised, kept
6,905
$0.61
$4.21K
David L. Lucchino
3 Aug 2021
President and CEO
Exercised, kept
6,905
$0.61
$4.21K
David L. Lucchino
1 Jul 2021
President and CEO
Exercised, kept
6,905
$0.61
$4.21K
David L. Lucchino
21 Jun 2021
President and CEO
Exercised, kept
113,690
$0.61
$69.35K
Joel S Marcus
25 Mar 2021
Director
Exercised, kept
37,116
$3.37
$125.08K
Showing 250 of 323 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 298
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 101
Sales straight out of an exercise 56
Sales at will 117
Transactions with no price 0
Shares from compensation/vesting 7,033,335
Sales filed before the plan box existed 100
History held since 2 Oct 2019